Biosion announces exclusive, global license agreement with aclaris therapeutics on two potential first-in-class and best-in-class immunology assets
Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9% shares of common stock of aclaris therapeutics; additional regulatory and sales milestone payments exceed $900m with tiered single digit sales royalty aclaris therapeutics will be responsible for development and commercialization of bsi-045b, a novel anti-tslp monoclonal antibody, and bsi-502, a novel bispecific antibody that is directed against both tslp and il4r worldwide (excluding greater china) newark, del. and nanjing, china , nov. 18, 2024 /prnewswire/ -- biosion, inc. (biosion), a global r&d stage biotechnology company, today announced that it has entered into an exclusive license agreement with aclaris therapeutics (nasdaq: acrs) for worldwide rights (excluding greater china) to bsi-045b, a potential first-in-class, clinical-stage, novel anti-tslp monoclonal antibody, and bsi-502, a potential best-in-class, pre-clinical stage, novel bispecific antibody that is directed against both tslp and il4r.
ACRS Ratings Summary
ACRS Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission